Search research articles
Contact Us
Filters
Showing results (631-640 of 657) with videos related to
Page
of 66
Sort By:
Endoscopy
|
February 13, 2021
Screening for upper gastrointestinal cancers with magnetically controlled capsule gastroscopy: a feasibility study
Zhen Li, Jing Liu, Chao-Ran Ji, et al.
Oncotarget
|
October 9, 2015
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine
Qi-Wei Jiang, Ke-Jun Cheng, Xiao-Long Mei, et al.
Leukemia
|
June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection
Ying Wang, Yang Liu, Xu Tan, et al.
Blood Cancer Journal
|
June 24, 2022
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Cheng Zhang, Jiaping He, Li Liu, et al.
Cancer Letters
|
November 20, 2016
Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer
Wen-Ji Zhang, Yong Li, Meng-Ning Wei, et al.
Cancer Biology & Therapy
|
March 22, 2019
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
Jiaxin Wu, Aoli Wang, Xixiang Li, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia
Xiaofei Liang, Beilei Wang, Cheng Chen, et al.
Cancer Cell International
|
July 2, 2025
Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities
Leiming Xia, Mengni Qu, Ling Ge, et al.
The Oncologist
|
April 30, 2026
Watchful Waiting in Children with Unifocal Osseous Langerhans Cell Histiocytosis
Chenxin Zhou, Haixia Yang, Shilin Liu, et al.
Journal of Hematology & Oncology
|
January 27, 2017
MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1
Pei Li, Yang Yang, Hui Liu, et al.
Page
of 66
Search research articles
Search
Showing results (631-640 of 657) with videos related to
Sort By:
Page
of 66
Endoscopy
|
February 13, 2021
Screening for upper gastrointestinal cancers with magnetically controlled capsule gastroscopy: a feasibility study
Zhen Li, Jing Liu, Chao-Ran Ji, et al.
Oncotarget
|
October 9, 2015
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine
Qi-Wei Jiang, Ke-Jun Cheng, Xiao-Long Mei, et al.
Leukemia
|
June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection
Ying Wang, Yang Liu, Xu Tan, et al.
Blood Cancer Journal
|
June 24, 2022
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Cheng Zhang, Jiaping He, Li Liu, et al.
Cancer Letters
|
November 20, 2016
Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer
Wen-Ji Zhang, Yong Li, Meng-Ning Wei, et al.
Cancer Biology & Therapy
|
March 22, 2019
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
Jiaxin Wu, Aoli Wang, Xixiang Li, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia
Xiaofei Liang, Beilei Wang, Cheng Chen, et al.
Cancer Cell International
|
July 2, 2025
Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities
Leiming Xia, Mengni Qu, Ling Ge, et al.
The Oncologist
|
April 30, 2026
Watchful Waiting in Children with Unifocal Osseous Langerhans Cell Histiocytosis
Chenxin Zhou, Haixia Yang, Shilin Liu, et al.
Journal of Hematology & Oncology
|
January 27, 2017
MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1
Pei Li, Yang Yang, Hui Liu, et al.
Page
of 66